VJHemOnc is committed to improving our service to you

ICML 2019 | MabCute results: extended subcutaneous R maintenance for indolent NHL

VJHemOnc is committed to improving our service to you

Simon Rule

Simon Rule, MD, Plymouth University, Plymouth, UK, discusses the Phase III MabCute study (NCT01461928), investigating prolonged maintenance with subcutaneous rituximab in relapsed/refractory indolent non-Hodgkin lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter